Correlation Between Martin Marietta and Swedish Orphan

Can any of the company-specific risk be diversified away by investing in both Martin Marietta and Swedish Orphan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Martin Marietta and Swedish Orphan into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Martin Marietta Materials and Swedish Orphan Biovitrum, you can compare the effects of market volatilities on Martin Marietta and Swedish Orphan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Martin Marietta with a short position of Swedish Orphan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Martin Marietta and Swedish Orphan.

Diversification Opportunities for Martin Marietta and Swedish Orphan

0.49

Correlation Coefficient

Martin Marietta  Swedish Orphan

Very weak diversification

The 3 months correlation between Martin and Swedish is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Martin Marietta Materials and Swedish Orphan Biovitrum in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swedish Orphan Biovitrum and Martin Marietta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Martin Marietta Materials are associated (or correlated) with Swedish Orphan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swedish Orphan Biovitrum has no effect on the direction of Martin Marietta i.e., Martin Marietta and Swedish Orphan go up and down completely randomly.

Pair Corralation between Martin Marietta and Swedish Orphan

Assuming the 90 days trading horizon Martin Marietta Materials is expected to under-perform the Swedish Orphan. But the stock apears to be less risky and, when comparing its historical volatility, Martin Marietta Materials is 1.41 times less risky than Swedish Orphan. The stock trades about -0.15 of its potential returns per unit of risk. The Swedish Orphan Biovitrum is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2,686  in Swedish Orphan Biovitrum on December 21, 2024 and sell it today you would lose (76.00) from holding Swedish Orphan Biovitrum or give up 2.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.33%
Values	Daily Returns

Martin Marietta Materials  vs.  Swedish Orphan Biovitrum

Martin Marietta Materials

Risk-Adjusted Performance

Very Weak

Over the last 90 days Martin Marietta Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Swedish Orphan Biovitrum

Risk-Adjusted Performance

Very Weak

Over the last 90 days Swedish Orphan Biovitrum has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Swedish Orphan is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Martin Marietta and Swedish Orphan

The main advantage of trading using opposite Martin Marietta and Swedish Orphan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Martin Marietta position performs unexpectedly, Swedish Orphan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swedish Orphan will offset losses from the drop in Swedish Orphan's long position.

The idea behind Martin Marietta Materials and Swedish Orphan Biovitrum pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.